chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Inappropriate schedule of product administration, Off label use
Clinical narrative: room temperature for more than 12 hours; interval > 35 days per her physician's recommendation; interval > 35 days per her physician's recommendation; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (interval > 35 days per her physician's recommendation), EXPIRED PRODUCT ADMINISTERED (room temperature for more than 12 hours) and OFF LABEL USE (interval > 35 days per her physician's recommendation) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 001B21A) for COVID-19 vaccination.     The patient's past medical history included Blood transfusion.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (interval > 35 days per her physician's recommendation) and OFF LABEL USE (interval > 35 days per her physician's recommendation). On 03-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (room temperature for more than 12 hours). On 03-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (interval > 35 days per her physician's recommendation), EXPIRED PRODUCT ADMINISTERED (room temperature for more than 12 hours) and OFF LABEL USE (interval > 35 days per her physician's recommendation) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   ? No treatment information was provided. ?
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dry skin, Erythema, Eye swelling, Hypersensitivity
Clinical narrative: Hypersensitivity reaction; red and swollen face; red and swollen eyes; dry face; could not see properly; swollen face; red and swollen eyes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), ERYTHEMA (red and swollen face), EYE SWELLING (red and swollen eyes), DRY SKIN (dry face) and VISUAL IMPAIRMENT (could not see properly) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O23621A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Gastrointestinal disorder (GI problems: on restricted diet) and Egg allergy (Throat swelled up,Could not swallow.) since 01-Dec-1956. Concomitant products included ALBUTEROL [SALBUTAMOL] from 02-Nov-1960 to an unknown date for Breathing difficult.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction), ERYTHEMA (red and swollen face), EYE SWELLING (red and swollen eyes), DRY SKIN (dry face), VISUAL IMPAIRMENT (could not see properly), SWELLING FACE (swollen face) and OCULAR HYPERAEMIA (red and swollen eyes). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. On 06-Jun-2021, HYPERSENSITIVITY (Hypersensitivity reaction), ERYTHEMA (red and swollen face), EYE SWELLING (red and swollen eyes), DRY SKIN (dry face), VISUAL IMPAIRMENT (could not see properly), SWELLING FACE (swollen face) and OCULAR HYPERAEMIA (red and swollen eyes) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 130/80 mmHg (abnormal) 130/80.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up received contains information about patient allergies and concomitant medications and updated outcome of events, additional event was updated
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Swelling face, Visual impairment
Clinical narrative: Hypersensitivity reaction; red and swollen face; red and swollen eyes; dry face; could not see properly; swollen face; red and swollen eyes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERSENSITIVITY (Hypersensitivity reaction), ERYTHEMA (red and swollen face), EYE SWELLING (red and swollen eyes), DRY SKIN (dry face) and VISUAL IMPAIRMENT (could not see properly) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O23621A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Gastrointestinal disorder (GI problems: on restricted diet) and Egg allergy (Throat swelled up,Could not swallow.) since 01-Dec-1956. Concomitant products included ALBUTEROL [SALBUTAMOL] from 02-Nov-1960 to an unknown date for Breathing difficult.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, the patient experienced HYPERSENSITIVITY (Hypersensitivity reaction), ERYTHEMA (red and swollen face), EYE SWELLING (red and swollen eyes), DRY SKIN (dry face), VISUAL IMPAIRMENT (could not see properly), SWELLING FACE (swollen face) and OCULAR HYPERAEMIA (red and swollen eyes). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. On 06-Jun-2021, HYPERSENSITIVITY (Hypersensitivity reaction), ERYTHEMA (red and swollen face), EYE SWELLING (red and swollen eyes), DRY SKIN (dry face), VISUAL IMPAIRMENT (could not see properly), SWELLING FACE (swollen face) and OCULAR HYPERAEMIA (red and swollen eyes) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 130/80 mmHg (abnormal) 130/80.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up received contains information about patient allergies and concomitant medications and updated outcome of events, additional event was updated
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Both doses of the Moderna Covid 19 vaccine were given to a 17 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Both doses of the Moderna Covid 19 vaccine were given to a 17 year old) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Both doses of the Moderna Covid 19 vaccine were given to a 17 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Both doses of the Moderna Covid 19 vaccine were given to a 17 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.            Within a week after second vaccine shot patient developed shingles. No concomitant medications were mentioned. No treatment details were reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (second shot of modern a is awful - feel this bad) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, the patient experienced FEELING ABNORMAL (second shot of modern a is awful - feel this bad). The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Reporter did not allow further contact.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hot flush, Hyperhidrosis, Menopause
Clinical narrative: hot flashes; sweating.; hot; it feels like going to menopause; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (hot flashes), HYPERHIDROSIS (sweating.), FEELING HOT (hot) and MENOPAUSE (it feels like going to menopause) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 045A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (hot flashes), HYPERHIDROSIS (sweating.), FEELING HOT (hot) and MENOPAUSE (it feels like going to menopause). At the time of the report, HOT FLUSH (hot flashes), HYPERHIDROSIS (sweating.), FEELING HOT (hot) and MENOPAUSE (it feels like going to menopause) outcome was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash macular
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pruritus (itchy arm), macular rash (couple of spots on ankles of either foot the same texture as arm rash) and rash in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026C21A and 047B21A) for COVID-19 immunization. Concurrent medical conditions included seasonal allergy. On May 1, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On May 29, 2021, received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On May 30, 2021, patient experienced pruritus (itchy arm), macular rash (couple of spots on ankles of either foot the same texture as arm rash) and rash. The patient treated with loratadine for rash; 1 dosage form. At the time of the report, pruritus (itchy arm), macular rash (couple of spots on ankles of either foot the same texture as arm rash) and rash outcome: unknown. Concomitant product use not provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Fall, Injury
Clinical narrative: Extremely, extremely dizzy; Lost his balance; Had a serious fall; Fell and hurt himself; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Extremely, extremely dizzy), BALANCE DISORDER (Lost his balance), FALL (Had a serious fall) and INJURY (Fell and hurt himself) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Extremely, extremely dizzy), BALANCE DISORDER (Lost his balance), FALL (Had a serious fall) and INJURY (Fell and hurt himself). At the time of the report, DIZZINESS (Extremely, extremely dizzy), BALANCE DISORDER (Lost his balance), FALL (Had a serious fall) and INJURY (Fell and hurt himself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.    Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow-up information received on 03-JUN-2021 contains significant information: Added new event "Hurt".
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Blister, Cystitis, Illness
Clinical narrative: SICK; vascular lesions on both her legs (around same spot each leg); bladder infection; no smell; no smell or taste; mouth hurt so bad; blisters formed both hands; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SKIN LESION (vascular lesions on both her legs (around same spot each leg)), CYSTITIS (bladder infection), ANOSMIA (no smell), AGEUSIA (no smell or taste) and ORAL PAIN (mouth hurt so bad) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03021A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included METOPROLOL for Blood pressure abnormal, VALSARTAN for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced BLISTER (blisters formed both hands). On 05-Mar-2021, the patient experienced SKIN LESION (vascular lesions on both her legs (around same spot each leg)), CYSTITIS (bladder infection), ANOSMIA (no smell), AGEUSIA (no smell or taste) and ORAL PAIN (mouth hurt so bad). On an unknown date, the patient experienced ILLNESS (SICK). The patient was treated with AMOXICILLIN for Root canal procedure, at a dose of UNK dosage form. On 18-Mar-2021, CYSTITIS (bladder infection), ANOSMIA (no smell) and AGEUSIA (no smell or taste) had resolved. On 25-Mar-2021, ORAL PAIN (mouth hurt so bad) and BLISTER (blisters formed both hands) had resolved. At the time of the report, SKIN LESION (vascular lesions on both her legs (around same spot each leg)) and ILLNESS (SICK) outcome was unknown.            Patient got biopsy and ultrasound done for vascular lesions on legs and results were pending at the time of this report. The patient got lots of fluids for bladder infection. The patient was sick for two weeks. The patient had root canal done 3 weeks after second shot (for dental problems).   This case was linked to MOD-2021-207472 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Oral pain, Skin lesion
Clinical narrative: SICK; vascular lesions on both her legs (around same spot each leg); bladder infection; no smell; no smell or taste; mouth hurt so bad; blisters formed both hands; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SKIN LESION (vascular lesions on both her legs (around same spot each leg)), CYSTITIS (bladder infection), ANOSMIA (no smell), AGEUSIA (no smell or taste) and ORAL PAIN (mouth hurt so bad) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03021A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included METOPROLOL for Blood pressure abnormal, VALSARTAN for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced BLISTER (blisters formed both hands). On 05-Mar-2021, the patient experienced SKIN LESION (vascular lesions on both her legs (around same spot each leg)), CYSTITIS (bladder infection), ANOSMIA (no smell), AGEUSIA (no smell or taste) and ORAL PAIN (mouth hurt so bad). On an unknown date, the patient experienced ILLNESS (SICK). The patient was treated with AMOXICILLIN for Root canal procedure, at a dose of UNK dosage form. On 18-Mar-2021, CYSTITIS (bladder infection), ANOSMIA (no smell) and AGEUSIA (no smell or taste) had resolved. On 25-Mar-2021, ORAL PAIN (mouth hurt so bad) and BLISTER (blisters formed both hands) had resolved. At the time of the report, SKIN LESION (vascular lesions on both her legs (around same spot each leg)) and ILLNESS (SICK) outcome was unknown.            Patient got biopsy and ultrasound done for vascular lesions on legs and results were pending at the time of this report. The patient got lots of fluids for bladder infection. The patient was sick for two weeks. The patient had root canal done 3 weeks after second shot (for dental problems).   This case was linked to MOD-2021-207472 (Patient Link).
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: received pfizer and moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (received pfizer and moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 20-Mar-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage form. On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (received pfizer and moderna vaccine). On 03-May-2021, INTERCHANGE OF VACCINE PRODUCTS (received pfizer and moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drugs were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Can the modern shot side effects be worse if exposed to another respiratory illness after 1st shot?; This spontaneous case was reported by a consumer and describes the occurrence of NO ADVERSE EVENT (Can the modern shot side effects be worse if exposed to another respiratory illness after 1st shot?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NO ADVERSE EVENT (Can the modern shot side effects be worse if exposed to another respiratory illness after 1st shot?). At the time of the report, NO ADVERSE EVENT (Can the modern shot side effects be worse if exposed to another respiratory illness after 1st shot?) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: tingling sensation on left hand going up to left forearm; numbness on the left hand going up to her left forearm.; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling sensation on left hand going up to left forearm) and HYPOAESTHESIA (numbness on the left hand going up to her left forearm.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, the patient experienced PARAESTHESIA (tingling sensation on left hand going up to left forearm) and HYPOAESTHESIA (numbness on the left hand going up to her left forearm.). At the time of the report, PARAESTHESIA (tingling sensation on left hand going up to left forearm) and HYPOAESTHESIA (numbness on the left hand going up to her left forearm.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Feeling drunk, Photopsia
Clinical narrative: Felt tipsy; Dizzy; was seeing stars; This spontaneous case was reported by a consumer and describes the occurrence of FEELING DRUNK (Felt tipsy), DIZZINESS (Dizzy) and PHOTOPSIA (was seeing stars) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced FEELING DRUNK (Felt tipsy), DIZZINESS (Dizzy) and PHOTOPSIA (was seeing stars). At the time of the report, FEELING DRUNK (Felt tipsy), DIZZINESS (Dizzy) and PHOTOPSIA (was seeing stars) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: headache; fever; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (headache) and PYREXIA (fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache) and PYREXIA (fever). At the time of the report, HEADACHE (headache) and PYREXIA (fever) outcome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: They are infected or quarantining from exposure to someone with active infection after the 1st dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE TO SARS-COV-2 (They are infected or quarantining from exposure to someone with active infection after the 1st dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (They are infected or quarantining from exposure to someone with active infection after the 1st dose). At the time of the report, EXPOSURE TO SARS-COV-2 (They are infected or quarantining from exposure to someone with active infection after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Confusional state
Clinical narrative: Confusion; This spontaneous case was reported by a patient and describes the occurrence of CONFUSIONAL STATE (Confusion) in an elderly patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided by the reporter. .     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On an unknown date, the patient experienced CONFUSIONAL STATE (Confusion). At the time of the report, CONFUSIONAL STATE (Confusion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information provided by the reporter. No  concomitant medical  provided by the reporter
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Nodule, Sleep disorder
Clinical narrative: 1 inch knot located in center of arm/knot above her arm pit inside that is visible/knot is an inch big/knot moves with the arm; knot is extremely sore; woke up this morning to the AE; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (1 inch knot located in center of arm/knot above her arm pit inside that is visible/knot is an inch big/knot moves with the arm), NODULE (knot is extremely sore) and SLEEP DISORDER (woke up this morning to the AE) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 026B21A) for COVID-19 vaccination.     The patient's past medical history included Nerve damage and Back surgery. Concurrent medical conditions included Diabetic, Epileptic seizure, Asthma and COPD. Concomitant products included PREGABALIN (LYRICA), LAMOTRIGINE, TOPIRAMATE (TOPIRAMAX), ATORVASTATIN, OMEPRAZOLE, ALBUTEROL [SALBUTAMOL], ERTUGLIFLOZIN PIDOLATE (STEGLATRO) and Breathing Treatments for an unknown indication.   On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jun-2021, the patient experienced AXILLARY MASS (1 inch knot located in center of arm/knot above her arm pit inside that is visible/knot is an inch big/knot moves with the arm), NODULE (knot is extremely sore) and SLEEP DISORDER (woke up this morning to the AE). At the time of the report, AXILLARY MASS (1 inch knot located in center of arm/knot above her arm pit inside that is visible/knot is an inch big/knot moves with the arm), NODULE (knot is extremely sore) and SLEEP DISORDER (woke up this morning to the AE) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  Concomitant medication included breathing treatments 3 times a day.  Treatment information was not provided.
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: kids, ages 16 and 17 received the Moderna vaccine on April 1st; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (kids, ages 16 and 17 received the Moderna vaccine on April 1st) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (kids, ages 16 and 17 received the Moderna vaccine on April 1st). On 01-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (kids, ages 16 and 17 received the Moderna vaccine on April 1st) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.   This case was linked to MOD-2021-207480 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blister
Clinical narrative: blisters on both hands; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (blisters on both hands) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL for Hypertension, VALSARTAN for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced BLISTER (blisters on both hands). The patient was treated with AMOXICILLIN at an unspecified dose and frequency. On 25-Mar-2021, BLISTER (blisters on both hands) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The blisters lasted for one month until the patient got her 2nd dose. After the second dose She took Amoxicillin for the dental treatment and that took all the blisters away.   This case was linked to MOD-2021-207418.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: didn't get noti;ied for his second vaccine of moderna; It has been 6weeks; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (didn't get noti;ied for his second vaccine of moderna) and PRODUCT DOSE OMISSION ISSUE (It has been 6weeks) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (didn't get noti;ied for his second vaccine of moderna) and PRODUCT DOSE OMISSION ISSUE (It has been 6weeks). At the time of the report, PRODUCT DOSE OMISSION ISSUE (didn't get noti;ied for his second vaccine of moderna) and PRODUCT DOSE OMISSION ISSUE (It has been 6weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (Diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Fatigue, Headache, Nausea, Product dose omission issue
Clinical narrative: an overwhelming sound in my left ear, tinnitus; pressure in the ear, like when flying on an airplane, pressure still present; nausea, like I was going to throw up, nauseated again; tired; headache; Missed second dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose of the Moderna COVID-19 vaccine), TINNITUS (an overwhelming sound in my left ear, tinnitus), EAR DISCOMFORT (pressure in the ear, like when flying on an airplane, pressure still present), NAUSEA (nausea, like I was going to throw up, nauseated again) and FATIGUE (tired) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D NOS for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose of the Moderna COVID-19 vaccine), NAUSEA (nausea, like I was going to throw up, nauseated again), FATIGUE (tired) and HEADACHE (headache). On an unknown date, the patient experienced TINNITUS (an overwhelming sound in my left ear, tinnitus) and EAR DISCOMFORT (pressure in the ear, like when flying on an airplane, pressure still present). The patient was treated with CORTISONE (oral) for Symptomatic treatment, at a dose of bid for 14 days. On 14-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Missed second dose of the Moderna COVID-19 vaccine) had resolved, NAUSEA (nausea, like I was going to throw up, nauseated again), FATIGUE (tired) and HEADACHE (headache) outcome was unknown. At the time of the report, TINNITUS (an overwhelming sound in my left ear, tinnitus) and EAR DISCOMFORT (pressure in the ear, like when flying on an airplane, pressure still present) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: an overwhelming sound in my left ear, tinnitus; pressure in the ear, like when flying on an airplane, pressure still present; nausea, like I was going to throw up, nauseated again; tired; headache; Missed second dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose of the Moderna COVID-19 vaccine), TINNITUS (an overwhelming sound in my left ear, tinnitus), EAR DISCOMFORT (pressure in the ear, like when flying on an airplane, pressure still present), NAUSEA (nausea, like I was going to throw up, nauseated again) and FATIGUE (tired) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D NOS for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose of the Moderna COVID-19 vaccine), NAUSEA (nausea, like I was going to throw up, nauseated again), FATIGUE (tired) and HEADACHE (headache). On an unknown date, the patient experienced TINNITUS (an overwhelming sound in my left ear, tinnitus) and EAR DISCOMFORT (pressure in the ear, like when flying on an airplane, pressure still present). The patient was treated with CORTISONE (oral) for Symptomatic treatment, at a dose of bid for 14 days. On 14-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Missed second dose of the Moderna COVID-19 vaccine) had resolved, NAUSEA (nausea, like I was going to throw up, nauseated again), FATIGUE (tired) and HEADACHE (headache) outcome was unknown. At the time of the report, TINNITUS (an overwhelming sound in my left ear, tinnitus) and EAR DISCOMFORT (pressure in the ear, like when flying on an airplane, pressure still present) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash
Clinical narrative: rash on her body located on her neck and back; allergies; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (rash on her body located on her neck and back) and HYPERSENSITIVITY (allergies) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE, FAMOTIDINE (PEPCID [FAMOTIDINE]), OMEPRAZOLE and HYDROXYZINE for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash on her body located on her neck and back) and HYPERSENSITIVITY (allergies). At the time of the report, RASH (rash on her body located on her neck and back) and HYPERSENSITIVITY (allergies) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reported the prednisone therapy had been prescribed for a body rash which had started prior to the first dose. The patient has asked the reporter if she can still have her second dose today, as the patient has read online about perhaps not having a dose if a person has allergies or rash. Since receiving the first dose, this rash has been diagnosed by an HCP as a dairy allergy.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patients, ages 16 and 17 received the Moderna vaccine on April 1st; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patients, ages 16 and 17 received the Moderna vaccine on April 1st) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patients, ages 16 and 17 received the Moderna vaccine on April 1st). On 01-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patients, ages 16 and 17 received the Moderna vaccine on April 1st) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment medications were provided by the reporter.   Reporter did not allow further contact
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Myalgia
Clinical narrative: Soreness; Time  between the first dose and the second is about 62 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Time  between the first dose and the second is about 62 days) and MYALGIA (Soreness) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Time  between the first dose and the second is about 62 days). On an unknown date, the patient experienced MYALGIA (Soreness). On 03-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Time  between the first dose and the second is about 62 days) had resolved. At the time of the report, MYALGIA (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-270267 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Significant follow-up: Event added
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Limb discomfort, Myalgia, Pain, Pain in extremity
Clinical narrative: Achy feeling; Started to feel like it affected her arms "really bad"; Hands hurt; Throbbing in arms and hands; Numb feeling in finger tips with prickly and tingly feeling; Numb feeling in finger tips with prickly and tingly feeling; Aches/pains; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Throbbing in arms and hands), PARAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), HYPOAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), PAIN (Aches/pains) and LIMB DISCOMFORT (Started to feel like it affected her arms "really bad") in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN (Aches/pains). On 17-Apr-2021, the patient experienced PAIN (Throbbing in arms and hands), PARAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), HYPOAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), LIMB DISCOMFORT (Started to feel like it affected her arms "really bad") and PAIN IN EXTREMITY (Hands hurt). On an unknown date, the patient experienced MYALGIA (Achy feeling). At the time of the report, PAIN (Throbbing in arms and hands), PARAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), HYPOAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), PAIN (Aches/pains), LIMB DISCOMFORT (Started to feel like it affected her arms "really bad"), PAIN IN EXTREMITY (Hands hurt) and MYALGIA (Achy feeling) outcome was unknown.            Patient was taking high blood pressure medication. Treatment medications  was not provided. The middle, pointer and thumb fingers are affected in both hands.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Significant Follow-up received on 26-JUN-2021: Events and concomitant medication were updated
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Achy feeling; Started to feel like it affected her arms "really bad"; Hands hurt; Throbbing in arms and hands; Numb feeling in finger tips with prickly and tingly feeling; Numb feeling in finger tips with prickly and tingly feeling; Aches/pains; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Throbbing in arms and hands), PARAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), HYPOAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), PAIN (Aches/pains) and LIMB DISCOMFORT (Started to feel like it affected her arms "really bad") in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN (Aches/pains). On 17-Apr-2021, the patient experienced PAIN (Throbbing in arms and hands), PARAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), HYPOAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), LIMB DISCOMFORT (Started to feel like it affected her arms "really bad") and PAIN IN EXTREMITY (Hands hurt). On an unknown date, the patient experienced MYALGIA (Achy feeling). At the time of the report, PAIN (Throbbing in arms and hands), PARAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), HYPOAESTHESIA (Numb feeling in finger tips with prickly and tingly feeling), PAIN (Aches/pains), LIMB DISCOMFORT (Started to feel like it affected her arms "really bad"), PAIN IN EXTREMITY (Hands hurt) and MYALGIA (Achy feeling) outcome was unknown.            Patient was taking high blood pressure medication. Treatment medications  was not provided. The middle, pointer and thumb fingers are affected in both hands.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Significant Follow-up received on 26-JUN-2021: Events and concomitant medication were updated
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: report a reaction to the moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (report a reaction to the moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (report a reaction to the moderna vaccine). At the time of the report, VACCINATION COMPLICATION (report a reaction to the moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Med Info Agent: Lohitha Pallerlamudi AE submitted via Chatbot  Patient had received Moderna vaccine and experienced a reaction to the Moderna vaccine.  No allergies, lab data, medical history was reported y patient. No concomitant and treatment medication was reported by patient. Consent to follow up with safety was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy). At the time of the report, DIZZINESS (Dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided